A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Oncolytics Biotech Inc stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 15,796 shares of ONCY stock, worth $13,426. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,796
Previous 13,294 18.82%
Holding current value
$13,426
Previous $13,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$0.87 - $1.08 $2,176 - $2,702
2,502 Added 18.82%
15,796 $13,000
Q2 2024

Aug 14, 2024

BUY
$0.99 - $1.24 $9,900 - $12,400
10,000 Added 303.58%
13,294 $13,000
Q1 2024

May 15, 2024

BUY
$0.89 - $1.36 $2,931 - $4,479
3,294 New
3,294 $4.68 Million
Q4 2023

Aug 14, 2024

SELL
$1.22 - $2.09 $897 - $1,538
-736 Reduced 18.26%
3,294 $4.36 Million
Q3 2023

Aug 14, 2024

BUY
$1.98 - $3.24 $2,952 - $4,830
1,491 Added 58.72%
4,030 $8.66 Million
Q2 2023

Aug 14, 2024

SELL
$1.11 - $2.74 $2,336 - $5,767
-2,105 Reduced 45.33%
2,539 $6.52 Million
Q1 2023

Aug 14, 2024

SELL
$1.2 - $1.91 $1,515 - $2,412
-1,263 Reduced 21.38%
4,644 $5.56 Million
Q4 2022

Aug 14, 2024

SELL
$1.17 - $2.12 $2,340 - $4,240
-2,000 Reduced 25.29%
5,907 $9.56 Million
Q3 2022

Aug 14, 2024

BUY
$0.98 - $1.51 $3,920 - $6,040
4,000 Added 102.38%
7,907 $9.81 Million
Q2 2022

Aug 14, 2024

BUY
$0.85 - $1.59 $425 - $795
500 Added 14.68%
3,907 $3.76 Million
Q1 2022

Aug 14, 2024

SELL
$1.31 - $2.02 $12,951 - $19,971
-9,887 Reduced 74.37%
3,407 $5.38 Million
Q2 2021

Aug 30, 2024

SELL
$2.6 - $4.64 $25,706 - $45,875
-9,887 Reduced 74.37%
3,407 $9.34 Million
Q1 2021

Aug 30, 2024

SELL
$2.32 - $4.11 $17,898 - $31,708
-7,715 Reduced 47.09%
8,670 $32.5 Million
Q4 2020

Aug 30, 2024

SELL
$1.71 - $4.03 $6,840 - $16,120
-4,000 Reduced 19.62%
16,385 $38.5 Million
Q3 2020

Aug 30, 2024

BUY
$1.58 - $2.15 $5,214 - $7,095
3,300 Added 19.32%
20,385 $34.6 Million
Q2 2020

Aug 30, 2024

BUY
$1.33 - $2.76 $11,970 - $24,839
9,000 Added 111.32%
17,085 $32.2 Million
Q1 2020

Aug 30, 2024

SELL
$0.98 - $4.28 $7,448 - $32,528
-7,600 Reduced 48.45%
8,085 $11.2 Million
Q4 2019

Aug 30, 2024

BUY
$0.42 - $4.76 $3,234 - $36,652
7,700 Added 96.43%
15,685 $74.3 Million
Q4 2018

Aug 30, 2024

SELL
$1.72 - $4.12 $9,131 - $21,873
-5,309 Reduced 39.94%
7,985 $14.3 Million
Q2 2018

Aug 30, 2024

SELL
$4.56 - $7.83 $24,209 - $41,569
-5,309 Reduced 39.94%
7,985 $42.8 Million

Others Institutions Holding ONCY

About ONCOLYTICS BIOTECH INC


  • Ticker ONCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 57,867,400
  • Market Cap $49.2M
  • Description
  • Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a...
More about ONCY
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.